Fenofibrate Tablet
Product Images NDC 50268-338

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 50268-338). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20 (338 12)

20 (338 12)
This is a description of medication with NDC 50260.338-12 identification number. The drug is Fenofibrate and is available in a pack of 20 tablets with two unit dosages. This medicine contains 4mg of Exchtabltconin enfbrta USP. Dosage varies and must be given according to the accompanying prescription. It should be stored at 25° (77), with excursions permitted by 1510 S0 (50 t085°F [0 USP Controlod Room Tompartrl Potet fom moltre. The medication should be kept out of reach of children, and its details indicate that it is only accessible by prescription. The medication is manufactured for AVKARE, and the packaging comes from P, TH 35478 AVRRK MG Rox.*
FDA Label Image

Fenofibrate-molecular Structure (4c2fcac5 1c6c 40e2 Bbde 267c4aa2821f 01)

FDA Label Image

4 (Table 4)

4 (Table 4)
The table displays the mean percent change in lipid parameters at the end of treatment. The table has three treatment groups categorized by baseline lipid values with different Total-C, LDLC, and HDL-C parameters. The percent change in lipid parameters, including Total-C, LDLC, and HDL-C, are displayed for each group, along with their baseline lipid values in mg/dL. The study treatment had a significant effect compared to the placebo.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.